PHAR Latest Press Releases

-- October 27, 2026 --

Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November Globe Newswire 2:00 AM

-- October 22, 2026 --

Pharming Group announces third quarter 2026 revenues above market expectations Globe Newswire 1:00 AM

-- October 14, 2026 --

Pharming presents positive Phase II topline data for leniolisib in genetic PIDs with immune dysregulation at ESID 2026 Globe Newswire 2:00 AM

-- September 29, 2026 --

Pharming announces CEO transition Globe Newswire 1:00 AM

-- September 25, 2026 --

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja to treat children with APDS Globe Newswire 10:30 AM

-- September 22, 2026 --

Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026 Globe Newswire 1:00 AM

-- September 11, 2026 --

FDA approves Pharming's Joenja as first treatment for children with APDS in the U.S. Globe Newswire 1:59 PM

-- September 9, 2026 --

Pharming Group to participate in September investor conferences Globe Newswire 2:00 AM

-- August 13, 2026 --

Pharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older Globe Newswire 1:00 AM

-- August 7, 2026 --

Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky PRNewswire 10:05 AM

-- August 6, 2026 --

Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Business Wire 11:00 AM

Pharming Group N.V. (PHAR) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation Business Wire 9:00 AM

-- August 5, 2026 --

Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz Business Wire 3:17 PM

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Pharming Group (PHAR) Globe Newswire 10:05 AM

-- August 4, 2026 --

PHAR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Pharming Group (PHAR) Business Wire 10:07 AM

Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference Globe Newswire 2:00 AM

-- August 3, 2026 --

PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group PRNewswire 10:07 AM

-- July 31, 2026 --

Pharming Group Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Pharming Group (PHAR) PRNewswire 4:58 PM

-- July 30, 2026 --

Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use Globe Newswire 1:00 AM

-- July 16, 2026 --

Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30 Globe Newswire 2:00 AM

Market Data Delayed 15 Minutes